One of the most challenging aspects of treating cancer is that, while there are commonalities, each person’s response to cancer and cancer treatments is unique. When cancer cells attack, some people are able to fight off cancer’s devastating effects and recover; others are not. Likewise, a cancer treatment that is effective in achieving long-term remission in one person may not be successful with another.
Biodynamic Imaging, an innovative cell imaging technique created by Purdue University researchers, may allow physicians to accurately determine the efficacy of cancer treatments on an individual. As Purdue research leader David Nolte told R&D Magazine:
“Technicians can use BioDynamic Imaging to measure tumor response to cancer therapy, such as metabolism and cell division. This can tell how well the drug is working and if there are side effects. Our approach is called phenotypic testing, which is more pertinent than genetic testing because it captures the holistic response of cancer to chemotherapy.”
The ability to determine individual response to chemotherapy, cancer vaccines and other cancer therapies could allow treatment teams to evaluate and identify more quickly treatment protocols that most benefit individual patients.
Early to recognize the uniqueness of each person’s response to cancer and cancer treatment, Issels Integrative Oncology began developing our innovative program of individualized immunotherapy more than 60 years ago. In six decades of successful practice, Issels cancer treatment teams have refined personalized cancer care and treatment using a holistic approach to boost immune response and fight cancer on multiple fronts. The success of our immunotherapy-based approach is evident in the many patient testimonials and documented case studies posted on our website.